TGFB1 and renal fibrosis: MRB treatment could inhibit MR activation, relieves macrophage infiltration to reduce the release of VEGFA and TGF-β1, etc., could inhibit abnormal angiogenesis and MMT, and could alleviate renal fibrosis.